Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.

Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.

Item
http://www.wikidata.org/entity/Q40918391
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.Identification of genes differentially expressed as result of adenovirus type 5- and adenovirus type 12-transformation.Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis.Application of genetic algorithms and constructive neural networks for the analysis of microarray cancer dataManufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cellsPerturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus.Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cellsSimplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element.Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.
P2860

Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.

Item
http://www.wikidata.org/entity/Q40918391
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.
@en
type
label
Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.
@en
prefLabel
Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P1433
P1476
Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity
@en
P2093
P304
P31
P407
P433
P478
P577
P698